Business Insights

BioMĂ©rieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMĂ©rieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Harbinger Health raises $140M in series B funding
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Artificial Intelligence Drug Design Funding Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
The U.S. Attorney's Office for the Middle District of Florida won a $370 million default judgment against a Kentucky lab owner and his businesses for a lab testing scheme intended to defraud Medicare.
September 28, 2023
Gavel Money Social
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Rna Strand Social
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Thermo Fisher Scientific executives voiced hopes for expanding work to help combat diseases at its giant $180 million viral vector manufacturing site in Plainville, MA.
September 27, 2023
Manufacturing Facility Process Social
Alzheimer’s drug approval poised to reshape APOE testing market
The U.S. Food and Drug Administration (FDA) approval of Biogen and Eisai’s Alzheimer’s disease drug Leqembi is likely to drive changes in the APOE testing market, according to an article in GenomeWeb.
September 25, 2023
Amyloid Plaque Alzheimer Social
Invitae receives noncompliance notice from NYSE
San Francisco-based medical genetics company Invitae received a notice of noncompliance from the New York Stock Exchange (NYSE) on September 20 for its stock price closing under $1.00 per share for 30 consecutive days.
September 25, 2023
Business Graph Money Stocks Social
Rome Therapeutics raises $72M in series B financing
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Dna Genome Gene Targeted Social
NIH to require international collaborators to share all data
Despite concerns from researchers and organizations, the U.S. National Institutes of Health (NIH) will implement its new mandate requiring foreign partners to share raw data and notebooks at regular set intervals with their primary U.S. grant recipients.
September 22, 2023
Lab Scientists Social
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
Broken String Biosciences raises $15M in series A financing round
Broken String Biosciences has closed a $15 million series A financing round.
September 19, 2023
Dna Sequence Shadow Social
Page 1 of 164
Next Page